Clinical Trials Browser

Phase 2 × monalizumab × 30 days × Clear all

NCT05903092 2026-03-12

MOZART

Phase 2 Suspended

Small Cell Lung Carcinoma

NCT05061550 2026-03-11

NeoCOAST-2

Phase 2 Recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms